Previous 10 | Next 10 |
2023-09-08 16:18:30 ET The CDC said Friday that antibodies produced by past COVID-19 infections or vaccinations appeared to be adequate in warding off the BA.2.86 variant, a new mutated strain of the virus that causes the disease, according to reports. The CDC added that the BA.2.86 var...
2023-09-08 15:00:57 ET More on the markets The Unemployment Rate Just Signaled That A Recession May Occur Within The Next 6 Months High Yield Signal Does Not Align With Bearish Outlook For SPY SPY: The Calm Before The Storm Bulls vs. Bears: SA analysts weigh ...
2023-09-07 06:19:36 ET Summary Novavax's lack of a proprietary drug and declining sales pose challenges for the company's future. Sales for Novavax's alternative vaccine may decline as demand for Covid vaccines decreases and supply exceeds demand. NVAX stock has limited long-t...
2023-09-06 16:46:35 ET More on Pfizer Seeking Alpha’s Quant Rating on Pfizer Historical earnings data for Pfizer Dividend scorecard for Pfizer Financial information for Pfizer Pfizer: The Floor To This Decline Remains To Be Seen Pfizer,...
2023-09-06 15:45:43 ET More on Pfizer, BioNTech, etc. Pfizer: The Floor To This Decline Remains To Be Seen BioNTech: Not Just Another Jab In The Arm Pfizer, Moderna And COVID Vaccine Patents: Implications Of Legal Cases Pfizer: Searching For A Bottom ...
2023-09-06 05:30:00 ET Novavax (NASDAQ: NVAX) shares have brought investors extremely good times and extremely bad times. They soared back in 2020 on hopes the biotech would score a win with its coronavirus vaccine candidate. But as Novavax fell behind in the race, the stock retreat...
2023-09-05 20:59:44 ET A potential upswing of COVID was the impetus behind a blast of interest in Novavax (NASDAQ: NVAX) stock on Tuesday. That morning, it was reported by various media outlets that first lady Jill Biden had tested positive for Covid the previous day. Novavax is...
2023-09-01 15:00:48 ET More on the markets My Current View Of The S&P 500 Index: September 2023 Edition The 'Big Short' Ignores Buffett And Bets Big On A Selloff: SPY Implications Is The Market Ignoring Signs Of An Imminent Debt Crisis? For further detail...
2023-08-31 10:07:00 ET Concerns around COVID-19 are diminishing but they are not going away entirely. New variants are emerging and case numbers have been climbing. One company that continues to work on developing an updated COVID vaccine is Novavax (NASDAQ: NVAX) . Last week, t...
2023-08-28 18:16:03 ET The latest rise in COVID-19 statistics is bringing investors back to coronavirus stocks. That, combined with a top-down effort to develop an updated vaccine and get it in the arms of as many Americans as possible, juiced several stocks associated with fighting the dis...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...